Healthcare -
Biotechnology - NASDAQ - US
$ 20.72
-1.57 %
$ 1.8 B
Market Cap
-4.58
P/E
TVTX - INTEREST INCOME & EXPENSE
Interest Income & Expense TVTX - Travere Therapeutics, Inc.
11.3 M
LAST VALUE
-24.98%
2 YEAR CAGR
2.93%
5 YEAR CAGR
-5.28%
10 YEAR CAGR